Intra-Cellular Therapies Inc reports results for the quarter ended in September 30 - Earnings Summary

Intra-Cellular Therapies

30/10/2024 15:21

* Intra-Cellular Therapies Inc  ITCI.OQ  reported a
quarterly
adjusted loss of 25 cents​​ per share for the quarter ended
September 30, identical to the same quarter last year.  The mean
expectation of fifteen analysts for the quarter was for a loss
of 20 cents per share. Wall Street expected results to range
from -33 cents to -9 cents per share.
    * Revenue rose 39% to $175.38 million from a year ago;
analysts
expected $172.35 million. 
    * Intra-Cellular Therapies Inc's reported EPS for the
quarter was
a loss of 25 cents​.
    * The company reported a quarterly loss of $26.32 million.
    * Intra-Cellular Therapies Inc shares had risen by 4.9% this
quarter and gained 7.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 39.1%
in the last three months.​ 
    * In the last 30 days, four analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 15 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Intra-Cellular
Therapies Inc is $95.00 
This summary was machine generated from LSEG data October 30 at
03:21 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.20          -0.25          Missed
 Jun. 30 2024      -0.19          -0.16          Beat
 Mar. 31 2024      -0.32          -0.16          Beat
 Dec. 31 2023      -0.44          -0.30          Beat